# Cholinergic Modulation of Condition and Emotion in Mood Disorders: Functional Neuroimaging Studies

> **NCT00055575** · PHASE2 · TERMINATED · sponsor: **National Institute of Mental Health (NIMH)** · enrollment: 197 (actual)

## Conditions studied

- Mood Disorders
- Healthy
- Unipolar Depression
- Bipolar Depression

## Interventions

- **DRUG:** Scopolamine Nasal Spray

## Key facts

- **NCT ID:** NCT00055575
- **Lead sponsor:** National Institute of Mental Health (NIMH)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-02-27
- **Primary completion:** 2015-02-02
- **Final completion:** 2015-02-02
- **Target enrollment:** 197 (ACTUAL)
- **Last updated:** 2021-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00055575

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00055575, "Cholinergic Modulation of Condition and Emotion in Mood Disorders: Functional Neuroimaging Studies". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00055575. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*